English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Community

+ Community
Erianne Leatherman | May 11, 2017

Study finds energy drinks have greater impact on heart, blood pressure than caffeine-only drinks

+ Community
Erianne Leatherman | May 11, 2017

Survey indicates signs of a 'mini' stroke are largely ignored

+ Regulatory
Erianne Leatherman | May 11, 2017

14 companies warned about falsely marketing cancer products

+ Technology/Innovation
Chandra Lye | May 11, 2017

Opdivo given European approval for patients with head and neck squamous cell cancer

+ Community
Erianne Leatherman | May 11, 2017

K2M’s Meeting of the Minds draws more than 100 spine surgeons

+ Community
Robert Hadley | May 10, 2017

Two Abbott drinks aimed at preparing patients for surgery

+ Regulatory
Carol Ostrow | May 10, 2017

Darzalex granted European Commission approval for multiple myeloma patients

+ Technology/Innovation
Robert Hadley | May 10, 2017

Health risk assessments may help identify early signs of depression

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 388
  • 389
  • 390
  • 391
  • 392
  • 393
  • 394
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily